B7-H3 and CSPG4-targeted CAR T cells as potent effectors in anaplastic thyroid cancer is a research paper published in Journal of Experimental & Clinical Cancer Research (2025). On theSindex it has a DataRank of 0. It has been cited 4 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph β no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full β never from an abstract alone.
National Institutes of Health
Grant: R01DE028172
National Institutes of Health
Grant: R03CA223886
U.S. Department of Defense
Grant: W81XWH2110433
U.S. Department of Defense
Grant: BC190615
National Cancer Institute
Grant: R03CA280302
National Institutes of Health
Grant: 1R03CA280302-01
Tumor downstaging with small molecule therapeutics to enhance Uveal Melanoma metastasis eradication by B7-H3 CAR T cells
National Institutes of Health
Grant: 1R03CA223886-01
Safety and anti-tumor activity of B7-H3 CAR T cells in TNBC
National Institutes of Health
Grant: 5R03CA231766-02
IL-15 TRiKES-based specific immunotherapy of pancreatic ductal adenocarcinoma
National Institutes of Health
Grant: 5R01DE028172-03
T cell plasticity, fusion proteins and CAR T cell-based immunotherapy of head and neck cancer
National Institutes of Health
Grant: 5R01CA226981-04
Prevention of post-therapy breast cancer metastasis
Bertarelli Foundation
Ruane Foundation
FWCI
1.88
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Additional file 1 of B7-H3 and CSPG4-targeted CAR T cells as potent effectors in anaplastic thyroid cancer
Additional file 1 of B7-H3 and CSPG4-targeted CAR T cells as potent effectors in anaplastic thyroid cancer